摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,5S,9S)-(+)-5,9-dimethyl-2'-hydroxy-2-<(1R)-1-phenylethyl>-6,7-benzomorphan | 146099-02-7

中文名称
——
中文别名
——
英文名称
(1S,5S,9S)-(+)-5,9-dimethyl-2'-hydroxy-2-<(1R)-1-phenylethyl>-6,7-benzomorphan
英文别名
(1S,9S,13S)-1,13-dimethyl-10-[(1R)-1-phenylethyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol
(1S,5S,9S)-(+)-5,9-dimethyl-2'-hydroxy-2-<(1R)-1-phenylethyl>-6,7-benzomorphan化学式
CAS
146099-02-7
化学式
C22H27NO
mdl
——
分子量
321.462
InChiKey
SYJWJFFGYLVLSU-DJDZNOHASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    23.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1S,5S,9S)-(+)-5,9-dimethyl-2'-hydroxy-2-<(1R)-1-phenylethyl>-6,7-benzomorphan 在 palladium on activated charcoal 盐酸氢气 作用下, 以 乙醇乙酸乙酯 为溶剂, 以69%的产率得到(2alpha,6alpha,11R*)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇
    参考文献:
    名称:
    A stereocontrolled alkylation of chiral pyridinium salts with Grignard reagents: synthesis of (+)-normetazocine and (+)-nordextrorphan
    摘要:
    The synthesis of chiral pyridinium salts 3, bearing lipophilic counteranions, is described. These salts, soluble in THF or toluene, undergo nucleophilic alkylation with benzylic Grignard reagents to give, after reduction of the unstable dihydropyridine intermediates, adducts 4 with regio- and stereoselective attack at position 2, the observed stereoselectivity ranging from 8:1 to 12.5:1. These results allowed an asymmetric synthesis, following Grewe's route, of (+)-normetazocine and (+)-nordextrorphan, key precursors of various benzomorphan or morphinan drugs.
    DOI:
    10.1021/jo00060a019
  • 作为产物:
    描述:
    4-methoxybenzylmagnesium chloride 在 sodium tetrahydroborate 、 氢溴酸 作用下, 反应 39.5h, 生成 (1S,5S,9S)-(+)-5,9-dimethyl-2'-hydroxy-2-<(1R)-1-phenylethyl>-6,7-benzomorphan
    参考文献:
    名称:
    A stereocontrolled alkylation of chiral pyridinium salts with Grignard reagents: synthesis of (+)-normetazocine and (+)-nordextrorphan
    摘要:
    The synthesis of chiral pyridinium salts 3, bearing lipophilic counteranions, is described. These salts, soluble in THF or toluene, undergo nucleophilic alkylation with benzylic Grignard reagents to give, after reduction of the unstable dihydropyridine intermediates, adducts 4 with regio- and stereoselective attack at position 2, the observed stereoselectivity ranging from 8:1 to 12.5:1. These results allowed an asymmetric synthesis, following Grewe's route, of (+)-normetazocine and (+)-nordextrorphan, key precursors of various benzomorphan or morphinan drugs.
    DOI:
    10.1021/jo00060a019
点击查看最新优质反应信息

文献信息

  • A stereocontrolled alkylation of chiral pyridinium salts with Grignard reagents: synthesis of (+)-normetazocine and (+)-nordextrorphan
    作者:Yves Genisson、Christian Marazano、Bhupesh C. Das
    DOI:10.1021/jo00060a019
    日期:1993.4
    The synthesis of chiral pyridinium salts 3, bearing lipophilic counteranions, is described. These salts, soluble in THF or toluene, undergo nucleophilic alkylation with benzylic Grignard reagents to give, after reduction of the unstable dihydropyridine intermediates, adducts 4 with regio- and stereoselective attack at position 2, the observed stereoselectivity ranging from 8:1 to 12.5:1. These results allowed an asymmetric synthesis, following Grewe's route, of (+)-normetazocine and (+)-nordextrorphan, key precursors of various benzomorphan or morphinan drugs.
查看更多

同类化合物

非那佐辛 酮佐辛盐酸盐 酮佐辛 莫克索兴 苄卡镇痛新 脱氧-N-苄基去甲美他佐辛 美他佐辛 环佐辛 环丙止痛胺 格各佐辛 布马佐辛 化合物 T27086 乳酸,化合物与(2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-六氢-6,11-二甲基-3-(3-甲基丁-2-烯基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇(1:1) N-(3-氟丙基)-N-去甲美他唑新 6-乙氧基-2,2,4-三甲基-1,2-二氢喹啉 6,11-二甲基-3-丙基-1,2,3,4,5,6-六氢-2,6-亚甲基-3-苯并吖辛因 5-乙基-2'-羟基-2(N)-(3-甲基-2-丁烯基)-9-甲基-6,7-苯并吗吩烷 3-苄基-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-己基-6,11-二甲基-1,2,3,4,5,6-六氢-2,6-亚甲基-3-苯并吖辛因 3-(环戊基甲基)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-(环丙基羰基)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-(环丁基甲基)-6,11-二甲基-1,2,3,4,5,6-六氢-8-甲氧基-2,6-甲桥-3-苯并氮杂环辛四烯 2-羟基-丙酸3-(环丁基甲基)-6-乙基-1,2,3,4,5,6-六氢-11,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-基酯 2-丙烯酸,2-甲基-,聚合丁基2-丙烯酸酯,乙烯基苯,2-羟基乙基2-丙烯酸酯,甲基2-甲基-2-丙烯酸酯和噁丙环基甲基2-甲基-2-丙烯酸酯 10-(环丙基甲基)-1,13-二甲基-10-氮杂三环[7.3.1.02,7]十三-2,4,6-三烯-4-醇 1,2,3,4,5,6-六氢-6-乙基-3-甲基-(+-)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-6,11-二甲基-3-(3-甲基丁-2-烯基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇盐酸盐 1,2,3,4,5,6-六氢-6,11-二甲基-3-(2-丙炔基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-环丁基甲基-6-乙基-1-甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(环丙基甲基)-6,11-二甲基-8-甲氧基-2,6-甲桥-3-苯并氮杂环辛四烯 1,2,3,4,5,6-六氢-3-(氰基甲基)-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(3,3-二氯-2-丙烯基)-6-乙基-11-甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(3,3-二氯-2-丙烯基)-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 (2alpha,6alpha,11R*)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 (2S-(2a,6a,11R)-1,2,3,4,5,6-六氢-6,11-二甲基-3-(2-丙烯基)-2,6-亚甲基-3-苯并吗吩烷-8-醇盐酸盐 (-)-布马佐辛盐酸盐 (-)-去甲美他佐辛 (-)-N-丙烯基去甲变肾上腺素 盐酸盐 (-)-5,9alpha-二乙基-2'-羟基苯并吗吩烷 (+-)-(2alpha,6alpha,11R*)-苯硫代羧酸S-(1,2,3,4,5,6-六氢-3,6,11-三甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-基)酯(E)-2-丁烯二酸盐(1:1)水合物 (+)-环佐辛 (+)-喷他佐辛 (+/-)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-2,6-methano-3-benzazocin-8-thiocarboxamide 8-carboxamidocyclazocine (+/-)-3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-N-(4-dimethylaminophenyl)-2,6-methano-3-benzazocin-8-amine (+)-pentazocine 5,9-dimethyl-2'-hydroxy-6,7-benzomorphan (-)-cis-2-(3,3-dimethylallyl)-5,9α-dimethyl-2'-fluoro-6,7-benzomorphan (+)-cis-2-(3,3-dimethylallyl)-5,9α-dimethyl-2'-fluoro-6,7-benzomorphan (-)-2'-fluoro-5,9α-dimethyl-6,7-benzomorphan